Tranylcypromine Treatment of Bipolar Depression
Condition(s):Bipolar Disorder I or IILast Updated:March 15, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Bipolar Disorder I or IILast Updated:March 15, 2018Completed
Condition(s):To Determine the Bioavailability of TranylcypromineLast Updated:April 4, 2008Completed
Condition(s):Major DepressionLast Updated:April 27, 2012Terminated
Condition(s):AMLLast Updated:July 7, 2015Unknown status
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:October 18, 2018Unknown status
Condition(s):Acute Myelogenous Leukemia; Myelodysplastic Syndromes; LeukemiaLast Updated:July 21, 2020Completed
Condition(s):Major Depressive DisorderLast Updated:September 18, 2014Terminated
Condition(s):MelasmaLast Updated:May 5, 2022Completed
Condition(s):Tranexamic Acid Adverse ReactionLast Updated:January 25, 2023Completed
Condition(s):Stroke Hemorrhagic; Intracerebral HaemorrhageLast Updated:October 17, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.